SEC Form 4 · accession 0001615774-17-003731
GlyEco, Inc. · GLYE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles F Trapp
Director
Period of report
May 22, 2015
Accepted (ET)
Jul 19, 2017 · 9:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000931799
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Jul 19, 2017 | A | 102,040 | $0.098 | A | 4,170,715 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock GrantF8,F4,F5 | — | May 22, 2015 | A | 175,676 | A | — | — | Common Stock | 175,676 | 175,676 | D |
| Restricted Stock GrantF8,F6,F7 | — | Dec 2, 2016 | A | 350,000 | A | — | — | Common Stock | 350,000 | 350,000 | D |
Explanation of responses
- F1Shares granted under the Company's Director Compensation Plan for the fiscal quarter ended June 30, 2017.
- F2Shares priced as of the close on April 3, 2017.
- F3The report reflects the correct amount of securities held by the reporting person. The balance reported on the Form 4 filed on April 4, 2017 overstated the amount of securities owned by the reporting person due to an administrative error.
- F4The Restricted Stock Grant represents a contingent right to receive 175,676 shares of Issuer common stock.
- F5The Restricted Stock Grant was granted pursuant to the Issuer's 2015 Director Compensation Plan on May 22, 2015, and vests upon the Issuer's common stock achieving a 30-day volume-weighted average price of $0.20.
- F6The Restricted Stock Grant represents a contingent right to receive 350,000 shares of Issuer common stock.
- F7The Restricted Stock Grant was granted in recognition of the director's service to the Issuer on December 2, 2016, and vests upon the Issuer's common stock achieving a 30-day volume-weighted average price of $0.20.
- F8The report reflects an updated amount of derivative securities held by the reporting person.